Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Amesanar by RHEACELL for Diabetic Foot Ulcers: Likelihood of Approval
Amesanar is under clinical development by RHEACELL and currently in Phase II for Diabetic Foot Ulcers. According to GlobalData, Phase...
Data Insights
Amesanar by RHEACELL for Venous Leg Ulcers (Crural Ulcer): Likelihood of Approval
Amesanar is under clinical development by RHEACELL and currently in Phase III for Venous Leg Ulcers (Crural Ulcer). According to...